OPATRILOVA, Radka, Martin CAPRNDA, Peter KUBATKA, Vanda VALENTOVA, Sona URAMOVA, Vladimir NOSAL, Ludovit GASPAR, Lukas ZACHAR, Ioana MOZOS, Daniel PETROVIC, Jozef DRAGASEK, Slavomira FILIPOVA, Dietrich BUSSELBERG, Anthony ZULLI, Luis RODRIGO, Peter KRUŽLIAK and Vladimir KRASNIK. Adipokines in neurovascular diseases. BIOMEDICINE & PHARMACOTHERAPY. PARIS: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2018, vol. 98, FEB 2018, p. 424-432. ISSN 0753-3322. Available from: https://dx.doi.org/10.1016/j.biopha.2017.12.074.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Adipokines in neurovascular diseases
Authors OPATRILOVA, Radka (203 Czech Republic), Martin CAPRNDA (703 Slovakia), Peter KUBATKA (703 Slovakia), Vanda VALENTOVA (703 Slovakia), Sona URAMOVA (703 Slovakia), Vladimir NOSAL (703 Slovakia), Ludovit GASPAR (703 Slovakia), Lukas ZACHAR (703 Slovakia), Ioana MOZOS (642 Romania), Daniel PETROVIC (705 Slovenia), Jozef DRAGASEK (703 Slovakia), Slavomira FILIPOVA (703 Slovakia), Dietrich BUSSELBERG (634 Qatar), Anthony ZULLI (36 Australia), Luis RODRIGO (724 Spain), Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution) and Vladimir KRASNIK (703 Slovakia).
Edition BIOMEDICINE & PHARMACOTHERAPY, PARIS, ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2018, 0753-3322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher France
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.743
RIV identification code RIV/00216224:14110/18:00102964
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.biopha.2017.12.074
UT WoS 000426104000053
Keywords in English Adipokines; Leptin; Adiponectin; Resistin; Apelin; Visfatin; Atherosclerosis; Ischemic stroke; Metabolic changes; Inflammation
Tags 14110121, EL OK, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 9/2/2019 20:01.
Abstract
Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke. Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis. Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses. Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke. Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke. These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases. In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke.
PrintDisplayed: 27/4/2024 05:24